Literature DB >> 27430124

Conjunctival allergen provocation test : guidelines for daily practice.

J-L Fauquert1, M Jedrzejczak-Czechowicz2, C Rondon3, V Calder4, D Silva5, B K Kvenshagen6, I Callebaut7, P Allegri8, N Santos5, S Doan9, D Perez Formigo10, F Chiambaretta11, L Delgado12, A Leonardi13.   

Abstract

Conjunctival allergen provocation test (CAPT) reproduces the events occurring by instilling an allergen on the ocular surface. This paper is the compilation of a task force focussed on practical aspects of this technique based on the analysis of 131 papers. Main mechanisms involved are reviewed. Indications are diagnosing the allergen(s)-triggering symptoms in IgE-mediated ocular allergy in seasonal, acute or perennial forms of allergic conjunctivitis, especially when the relevance of the allergen is not obvious or in polysensitized patients. Contraindications are limited to ongoing systemic severe pathology, asthma and eye diseases. CAPT should be delayed if receiving systemic steroids or antihistamines. Local treatment should be interrupted according to the half-life of each drug. Prerequisites are as follows: obtaining informed consent; evidencing of an allergen by skin prick tests and/or serum-specific IgE dosages; being able to deal with an unlikely event such as acute asthma exacerbation, urticaria or anaphylaxis, or an exacerbation of allergic conjunctivitis. Allergen extracts should be diluted locally prior to administration. Positive criteria are based on itching or quoted according to a composite score. An alternative scoring is based on itching. CAPT remains underused in daily practice, although it is a safe and simple procedure which can provide valuable clinical information.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  allergen challenge; conjunctivitis; in vivo diagnosis; ocular surface; ocular surface diagnosis; provocation test

Mesh:

Substances:

Year:  2016        PMID: 27430124     DOI: 10.1111/all.12986

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  20 in total

1.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

2.  IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper.

Authors:  Ignacio J Ansotegui; Giovanni Melioli; Giorgio Walter Canonica; Luis Caraballo; Elisa Villa; Motohiro Ebisawa; Giovanni Passalacqua; Eleonora Savi; Didier Ebo; R Maximiliano Gómez; Olga Luengo Sánchez; John J Oppenheimer; Erika Jensen-Jarolim; David A Fischer; Tari Haahtela; Martti Antila; Jean J Bousquet; Victoria Cardona; Wen Chin Chiang; Pascal M Demoly; Lawrence M DuBuske; Marta Ferrer Puga; Roy Gerth van Wijk; Sandra Nora González Díaz; Alexei Gonzalez-Estrada; Edgardo Jares; Ayse Füsun Kalpaklioğlu; Luciana Kase Tanno; Marek L Kowalski; Dennis K Ledford; Olga Patricia Monge Ortega; Mário Morais Almeida; Oliver Pfaar; Lars K Poulsen; Ruby Pawankar; Harald E Renz; Antonino G Romano; Nelson A Rosário Filho; Lanny Rosenwasser; Mario A Sánchez Borges; Enrico Scala; Gian-Enrico Senna; Juan Carlos Sisul; Mimi L K Tang; Bernard Yu-Hor Thong; Rudolf Valenta; Robert A Wood; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2020-02-25       Impact factor: 4.084

3.  Liposomal Eye Spray Is as Effective as Antihistamine Eye Drops in Patients with Allergic Rhinoconjunctivitis Induced by Conjunctival Provocation Testing.

Authors:  Anne-Nele Grzella; Sabine Schleicher; Kija Shah-Hosseini; Anatoli Astvatsatourov; Esther Raskopf; Silke Allekotte; Ralph Mösges
Journal:  Int Arch Allergy Immunol       Date:  2019-03-25       Impact factor: 2.749

4.  [Corneal alterations in eyelid diseases].

Authors:  Elisabeth M Messmer
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

5.  Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis.

Authors:  Yifan Meng; Hongshuang Lu; Chengshuo Wang; Yang Wang; Na Meng; Ke Yang; Ying Jie; Luo Zhang
Journal:  World Allergy Organ J       Date:  2021-05-09       Impact factor: 4.084

Review 6.  Clinical trials in allergen immunotherapy: current concepts and future needs.

Authors:  O Pfaar; M Alvaro; V Cardona; E Hamelmann; R Mösges; J Kleine-Tebbe
Journal:  Allergy       Date:  2018-04-16       Impact factor: 13.146

7.  Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing.

Authors:  S Zielen; P Kuna; W Aberer; S Lassmann; O Pfaar; L Klimek; A Wade; K Kluehr; J Raab; D Wessiepe; D Lee; M F Kramer; K Gunawardena; T Higenbottam; M D Heath; M A Skinner; P J de Kam
Journal:  World Allergy Organ J       Date:  2019-10-25       Impact factor: 4.084

Review 8.  China Consensus Document on Allergy Diagnostics.

Authors:  Hao Chen; Jing Li; Lei Cheng; Zhongshan Gao; Xiaoping Lin; Rongfei Zhu; Lin Yang; Ailin Tao; Haiyu Hong; Wei Tang; Yinshi Guo; Huaiqiu Huang; Jinlyu Sun; He Lai; Cheng Lei; Guanghui Liu; Li Xiang; Zhuanggui Chen; Han Ma; Alson Wai Ming Chan; Chuangli Hao; Baoqing Sun
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

9.  A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.

Authors:  R Mösges; E M Kasche; E Raskopf; J Singh; L Sohlich; A Astvatsatourov; K Shah-Hosseini; S Pirotton; L Haazen; S R Durham; T Legon; G Zadoyan; M H Shamji
Journal:  Allergy       Date:  2017-12-22       Impact factor: 13.146

Review 10.  Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.

Authors:  Heimo Breiteneder; Ya-Qi Peng; Ioana Agache; Zuzana Diamant; Thomas Eiwegger; Wytske J Fokkens; Claudia Traidl-Hoffmann; Kari Nadeau; Robyn E O'Hehir; Liam O'Mahony; Oliver Pfaar; Maria J Torres; De-Yun Wang; Luo Zhang; Cezmi A Akdis
Journal:  Allergy       Date:  2020-09-30       Impact factor: 14.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.